Restrictions on sales activities and demand fluctuations caused by COVID-19
First written in FY2022-Q3. 5 of 8 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2020: 119 of 169 companies on the "Worse" side.
41 other companies' latest entry also says "Dropped".
- FY2024DroppedAnnual report
「In preparation for natural disasters and other events, we will continue to improve and implement measures to minimise business risks, including regular disaster-prevention activities and operation of our BCP.」
In the FY2024 discussion of management issues and business risks, there was no reference to COVID-19, and only preparations for natural disasters and other events were described. - FY2024-Q2RestatedAnnual report
「During the six-month cumulative period of the current consolidated fiscal year, the Japanese economy remained on a moderate recovery trend, owing to the easing of various restrictions following the downgrading of COVID-19 under the Infectious Diseases Control Law.」
The report describes the recovery trend in the domestic economy following the reclassification of COVID-19 under the Infectious Diseases Act and regulatory relaxation. It states that there have been no new business risks or material changes to existing risks. - FY2024-Q1MitigatedAnnual report
「During the three-month cumulative period of the current consolidated fiscal year, the Japanese economy remained on a moderate recovery trend, owing to the easing of various restrictions following the downgrading of COVID-19 under the Infectious Diseases Control Law.」
The Group described the Japanese economy as remaining on a moderate recovery trend due to the downgrading of COVID-19 under the Infectious Diseases Control Law and the easing of restrictions. It also stated that there were no material changes in business and other risks. - FY2023-Q3RestatedAnnual report
「During the nine-month cumulative period of the current consolidated fiscal year, the Japanese economy remained on a moderate recovery trend, owing to the easing of restrictions on activity as vaccination against COVID-19 progressed and other factors, but there was still no clear prospect of COVID-19 coming to an end, and uncertainty about the outlook continued.」
The Group referred to recovery factors from the easing of restrictions on activity, while continuing to describe the absence of a clear prospect for the end of COVID-19. - FY2023-Q2RestatedAnnual report
「The Japanese economy remained on a moderate recovery trend, owing to the easing of restrictions on activity as vaccination against COVID-19 progressed and other factors, but there was still no clear prospect of COVID-19 coming to an end, and uncertainty about the outlook continued.」
The Group referred to recovery factors from the easing of restrictions on activity, while continuing to describe the absence of a clear prospect for the end of the infectious disease outbreak. - FY2023-Q1RestatedAnnual report
「There was no clear prospect of COVID-19 coming to an end, and uncertainty about the outlook continued.」
The Group continues to describe the risk that the end of the infectious disease outbreak remains unforeseeable, while referring to vaccinations and the easing of restrictions on activity. - FY2022RestatedAnnual report
「The impact on the economy of exceptional events, including the spread of COVID-19 and other infectious diseases, is expected to extend to domestic and overseas demand, and we anticipate that the difficult operating environment will continue.」
The Group continues to describe the risk that a resurgence of infectious diseases will affect demand, production, logistics and sales activities. - FY2022-Q3MaterialisedAnnual report
「Social and economic activity was restricted amid concerns about a resurgence of COVID-19, and uncertainty about the outlook continued.」
The Group stated that there were no new risks, while describing the impact of the spread of the infection in restricting social, economic and sales activities and slowing product demand.